NCT05199753
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05199753
Title Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors LaNova Australia Pty Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Blacktown Hospital Sydney New South Wales NSW 2148 Australia Details
Sunshine Coast University Private Hospital Birtinya Queensland QLD 4575 Australia Details
ICON Cancer Centre South Brisbane Queensland QLD 4101 Australia Details
Cabrini Health Limited Malvern Victoria VIC 3144 Australia Details
Alfred Hospital Melbourne Victoria VIC 3004 Australia Details
One Clinical Research Pty Ltd. Nedlands Western Australia WA 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field